$FFIV

Buse Elizabeth sold $399K of FFIV

Buse Elizabeth sold 1,000 shares of F5, INC. (FFIV) at an average of $399.35 ($398.53–$401.05, $0.40M total) across 4 trades on 2026-06-10.

Original reporting
SEC EDGAR · Buse Elizabeth
Published Jun 12, 2026, 9:39 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 12, 2026, 9:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FFIV
Neutral
high confidence
Mentioned
$FFIV
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FFIVNeutralLow
01

Why it matters

The disclosure provides a fresh, primary-source datapoint on director selling activity, but it does not include earnings, guidance, or operational changes.

02

Market read

Traders may monitor whether this sale is part of a broader pattern of insider behavior, but the filing alone is unlikely to drive a sustained repricing.

03

What to watch

Check for clustering of insider sales/buys around the same period and whether other directors/officers executed similar trades; one Form 4 alone is weak evidence.

Relevance 4/10Novelty 6/10Timing: Filed 2026-06-12; sale executed 2026-06-10.

Background

The article summarizes an SEC Form 4 insider transaction for F5, Inc. (FFIV).

Company-level read

Ticker impact

$FFIVNeutralHigh confidence
Context

Director Buse Elizabeth filed an open-market sale of 1,000 FFIV shares on 2026-06-10 (weighted avg ~$399.35).

Expected impact

Low near-term impact; any effect is likely noise unless paired with other insider activity or fundamental changes.

Evidence & confidence

This is a Form 4 insider sale with no 10b5-1 plan stated and no accompanying fundamental disclosure; such prints typically have modest standalone price impact.

Market effects

Minimal—single-company insider sale without sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the filing notes no 10b5-1 plan, the sale could reflect liquidity needs rather than bearish views; treat as non-informational unless insider selling accelerates.

Key entities

  • F5, Inc.

    Company whose shares were sold by a director via open-market transactions.

  • Buse Elizabeth

    Director who sold 1,000 shares of FFIV on 2026-06-10.

Related articles

$FFIVMed

5 Revealing Analyst Questions From F5’s Q2 Earnings Call

F5 reported Q2 results above Wall Street expectations, with revenue of $865.1M vs $835M estimates and adjusted EPS of $4.73 vs $4.00. Management cited 19% product revenue growth and demand for application security and delivery. Q3 guidance midpoint revenue is $880M and full-year adjusted EPS guidance is $17.27. Analysts questioned AI-driven growth, hardware refresh, and sustainability.